Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.36 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.36 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | CTSA | P10619 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL575640 | 0.92 | TSHR (0.43) | CYP3A4MEN1KMT2ATSHRLPAR3 | |
| SCHEMBL575843 | 0.90 | CYP3A4 (0.58) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL575509 | 0.87 | — | — | |
| SCHEMBL1470005 | 0.84 | LMNA (0.36) | CYP3A4MEN1KMT2ATSHRLMNA | |
| SCHEMBL1009310 | 0.83 | CYP3A4 (0.64) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL1009674 | 0.82 | — | — | |
| SCHEMBL10403951 | 0.82 | CYP3A4 (0.42) | CYP3A4MEN1KMT2ATSHRLPAR3 | |
| SCHEMBL10058455 | 0.82 | — | — | |
| SCHEMBL2459737 | 0.81 | LPAR3 (0.58) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL9938963 | 0.81 | CTSA (0.58) | CYP3A4MEN1KMT2ACTSAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1204157-B1 | Electrolyte for non-aqueous batteries and secondary battery using the same | PANASONIC CORP (JP) | 2010-03-24 | — | — | EP | claimed |
| CN-1946352-A | Methods and articles for delivering drugs to the eye for treatment of posterior segment disease | DIRECTCONTACT LLC (US) | 2007-04-11 | — | — | CN | claimed |
| EP-1204157-A2 | Electrolyte for non-aqueous batteries and secondary battery using the same | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2002-05-08 | — | — | EP | claimed |
| EP-4730479-A2 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | Kyoto University (JP) | 2026-04-22 | — | — | EP | disclosed |
| US-20250246685-A1 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | KYOTO UNIVERSITY (JP) | 2025-07-31 | — | — | US | disclosed |
| EP-4428982-A1 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | Kyoto University (JP) | 2024-09-11 | — | — | EP | disclosed |
| US-20240297344-A1 | NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-05 | — | — | US | disclosed |
| CN-118056309-A | Flame-retardant nonaqueous electrolyte and secondary battery using same | 国立大学法人京都大学 | 2024-05-17 | — | — | CN | disclosed |
| WO-2024073802-A1 | METHOD OF DETECTION | THE UNIVERSITY OF QUEENSLAND (AU) | 2024-04-11 | — | — | WO | disclosed |
| EP-4314774-A1 | METHOD OF DETECTION | The University of Queensland (AU) | 2024-02-07 | — | — | EP | disclosed |
| US-20230321281-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISEASES | FTGEN Corp | 2023-10-12 | — | — | US | disclosed |
| EP-1204157-B1 | Electrolyte for non-aqueous batteries and secondary battery using the same | PANASONIC CORP (JP) | 2010-03-24 | — | — | EP | disclosed |
| EP-2144321-A1 | NONAQUEOUS ELECTROLYTE FOR RECHARGEABLE BATTERY, AND RECHARGEABLE BATTERY WITH NONAQUEOUS ELECTROLYTE | Mitsubishi Chemical Corporation (JP) | 2010-01-13 | — | — | EP | disclosed |
| US-20080254361-A1 | Non-Aqueous Electrolyte for Battery and Non-Aqueous Electrolyte Secondary Battery Comprising the Same | BRIDGESTONE CORPORATION (JP) | 2008-10-16 | — | — | US | disclosed |
| US-20080153005-A1 | Non-Aqueous Electrolyte and Non-Aqueous Electrolyte Battery Comprising the Same | BRIDGESTONE CORPORATION (JP) | 2008-06-26 | — | — | US | disclosed |
| EP-1798792-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, AND NONAQUEOUS ELECTROLYTE BATTERY HAVING SAME | Bridgestone Corporation (JP) | 2007-06-20 | — | — | EP | disclosed |
| CN-1946352-A | Methods and articles for delivering drugs to the eye for treatment of posterior segment disease | DIRECTCONTACT LLC (US) | 2007-04-11 | — | — | CN | disclosed |
| US-6682857-B2 | A NON-AQUEOUS ELECTROLYTE INCLUDING AT LEAST ONE PHOSPHORIC ESTER DERIVATIVE EXPRESSED BY FORMULA (R1AO)(R2AO)P(O)X AND BY FORMULA R(1BO)P(O)X2, WHEREIN R1A, R2A, AND R1B INDEPENDENTLY DENOTE ALIPHATIC HYDROCARBON GROUPS | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2004-01-27 | — | — | US | disclosed |
| US-20020081497-A1 | Electrolyte for non-aqueous batteries and secondary battery using the same | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD | 2002-06-27 | — | — | US | disclosed |
| EP-1204157-A2 | Electrolyte for non-aqueous batteries and secondary battery using the same | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2002-05-08 | — | — | EP | disclosed |